A practical guide to the analytical methods that confirm the identity, chromatographic purity, and net peptide content of a synthesized peptide, and how those distinct measurements determine whether a batch can be trusted in quantitative biological assays. Covers HPLC and RSLC purity at 210-220 nm,…
When a synthetic peptide arrives as a lyophilized powder, three numbers decide whether it is usable in a biological assay: identity , chromatographic purity , and net peptide content . They answer different questions. Identity asks whether the molecule requested is the molecule in the tube. Purity asks what fraction of the peptide material is the desired sequence rather than truncated or modified by-products. Net peptide content asks how much of the powder's mass is peptide of any kind, as opposed to water, residual solvent, and counterions. None of the three can be inferred from the others, and using the wrong one in a calculation produces the wrong concentration.
The consequences land directly in the assay. A balance weighs everything in the tube, including mass that is not peptide. A solution made by weight alone and corrected only for the nominal purity is systematically more dilute than intended, and the size of the error changes from batch to batch. In an impure batch the problem is worse than dilution. By-products may bind the same receptor, act as substrates for the same enzyme, or raise an immune response to the wrong epitopes, so the experiment ends up measuring a mixture rather than the target peptide.
This article sets out the analytical methods behind each of the three numbers, their strengths and blind spots, how the results are documented, and how a researcher should use them when choosing a grade and preparing solutions.
Identity is a comparative exercise. A measured property of the product is matched against a value from the literature or from a reference sample, and identity is established by agreement across a panel of methods that probe different physical properties.
Chromatographic behavior is the most widely used check. In thin-layer chromatography, the sample migrates with the solvent, and the retention factor Rf is the distance traveled by the substance spot divided by the distance traveled by the solvent front. Rf is always less than 1 and depends on the mobile phase. A single spot indicates one component. When sample and reference are applied together and migrate as a single spot, the two materials are chromatographically identical, a test called co-elution . Analytical HPLC runs the same logic at higher resolution, and for peptides co-elution of the product with a reference sample as a single peak is the standard identity statement.
Mass spectrometry determines the molecular weight by ionizing the peptide and measuring the mass-to-charge ratio. The measured value is compared with the value calculated from the requested sequence, and agreement supports identity. Mass spectrometry is fast, requires very little material, and is the single most informative identity check for a peptide. It does not report the sequence, only the total mass, so it cannot by itself detect a scrambled sequence with the same elemental composition.
Elemental analysis confirms chemical composition. Carbon, hydrogen, nitrogen, and sometimes sulfur are measured and compared with the values calculated from the molecular formula, written for a peptide or amino acid derivative in the general form CxHyNzOwSv. Oxygen is measured only in exceptional cases. Infrared, NMR, and ultraviolet spectroscopy contribute structural signatures. Melting point and optical rotation are compared with literature or reference values. These methods are mainstays for amino acid derivatives, which are small molecules with well-defined physical constants; for longer peptides they support HPLC co-elution and mass spectrometry rather than replacing them.
Amino acid analysis takes a different approach. Strong acid hydrolysis breaks the peptide into its individual amino acids, and chromatographic separation quantifies each one. The measured residue ratios are compared with the composition of the requested sequence. The method gives composition, not sequence. It cannot reveal the order of the residues, and a peptide with the correct amino acids in the wrong order would satisfy it. Amino acid analysis is therefore a composition check, useful for detecting gross errors, not a structural proof.
Chromatographic purity is measured by analytical HPLC, or by the faster RSLC variant, with UV detection at 210-220 nm, the wavelength range where the peptide bond absorbs. Purity is expressed as the area of the main peak divided by the total peak area. A batch reported at 95% purity is one in which the target peptide accounts for 95 of every 100 units of UV-absorbing material that elutes from the column.
That definition carries three limits. First, purity is a ratio within the peptide fraction, not a fraction of the powder. Water, salts, and residual solvents never enter the integration. Second, anything that does not absorb at 210-220 nm is invisible to the measurement. Third, anything that co-elutes with the main peak is counted as part of it. A deletion sequence with similar charge and hydrophobicity can ride under the main peak and inflate the reported purity.
Optical purity is a separate parameter, and it matters most for amino acid derivatives and loaded resins. It measures the correct enantiomer against the incorrect one. Chromatographic purity does not address stereochemistry. A racemized building block can pass a standard HPLC purity test while carrying the wrong configuration into every peptide made from it; the optical purity determination is the check that catches that error.
Net peptide content NPC is the percentage of peptide material in the powder relative to non-peptidic material: counterions and moisture. A lyophilized peptide typically contains residual water, residual solvents, and acid salts. Trifluoroacetic acid is introduced by TFA-based HPLC purification and forms salts with the free N-terminus and the basic side chains of arginine, lysine, and histidine. Acetate appears when a peptide is prepared as the acetate salt. These components are not trace artifacts; they are stoichiometric consequences of the peptide's charge.
Each component of the non-peptide fraction is measured directly.
| Measured component | Analytical method |
|---|---|
| Water | Karl Fischer titration |
| Residual volatile solvents | Gas chromatography |
| Acetic acid | HPLC or ion chromatography |
| Trifluoroacetic acid | Ion chromatography |
| Acidic or basic content | Acid/base titration |
| Halides chloride, bromide | Silver nitrate titration |
| Nitrogen content | Elemental analysis |
The nitrogen content from elemental analysis serves as an independent check on the peptide mass. The measurements are assembled into the NPC figure. The key conceptual point is that NPC and HPLC purity are not equivalent. NPC counts peptidic contaminants as part of the peptide content, because they are peptide material; purity counts only the desired main peak. And the two numbers sit on different bases: purity is calculated only over peptide material, while NPC accounts for the entire powder, including water and salts.
The practical consequence is counterintuitive. Extremely pure peptides rich in basic amino acids, and hydrophilic peptides, are the ones most prone to salt formation and moisture uptake, so their NPC can be low even when the HPLC trace looks excellent. NPC also shifts with peptide polarity, the conditions of lyophilization, storage conditions, and exposure to humidity. The number printed on the certificate describes the batch at the time of analysis, not forever.
TFA deserves a special warning. It cannot be completely removed from a peptide, because salt formation stabilizes it. When an assay is sensitive to TFA, for example in some cell-based work, the remedy is to convert the peptide to a more biocompatible salt form, usually acetate, through an additional ion-exchange step. That conversion is a separate processing operation and changes the salt stoichiometry, which in turn changes the NPC.
Purity is a batch attribute, not a molecular constant. A peptide ordered at 80% purity can arrive at any purity from 80% to 100%, and the variability is more noticeable at lower purity levels. The reason is inherent to solid-phase synthesis. Each run accumulates its own profile of failure sequences: deletion products from incomplete couplings, terminated chains, and side products from deprotection and cleavage. Two batches cut to the same nominal purity can contain different by-products in different proportions, and the certificate from one batch says nothing certain about the next.
The biological consequences are real. Peptidic by-products may have biological activity different from the target peptide. A truncated analog can still bind a receptor or act as an enzyme substrate, so a batch of low-purity material behaves as a mixture whose composition varies with the synthesis. That variability is one of the most common hidden causes of irreproducible dose-response curves.
Non-peptidic impurities are a separate hazard, mostly confined to unpurified material. Unpurified peptides should not be used for accurate biological assays, because they may contain scavengers and other reagents from the cleavage step that are harmful to cells, enzymes, or receptors. After standard purification and lyophilization, cytotoxic non-peptidic contaminants such as residual solvents and scavengers are present only at trace levels.
Two practical rules follow. Read the certificate's chromatogram, not just its headline purity: the size and positions of the minor peaks describe the by-product profile that the percentage averages away. And for any quantitative assay, treat the batch as a batch. Replicate measurements within a study should use the same batch, and the certificate should be retained with the data.
Commercial suppliers sell research peptides in standard purity grades, and the grade should be matched to the tolerance of the intended assay. Bachem, a peptide manufacturer, defines four standard grades, with intermediate ranges available on request. The grade is a promise about the batch; the certificate documents what was delivered.
| Purity grade | Recommended applications |
|---|---|
| 95% | NMR and crystallography studies; reference peptides in quantitative enzyme-substrate, receptor-ligand, blocking, and competition assays |
| 90-95% | Monoclonal antibody production; quantitative enzyme-substrate, receptor-ligand, blocking, competition, and immunoassays; in vivo and in vitro studies |
| 80% | Qualitative Western blotting; qualitative enzyme-substrate studies; phosphorylation studies |
| Immunograde 65% | Polyclonal antibody production; antibody titer determination in standard immunoassays |
The reasoning behind the mapping is straightforward. A competition or receptor-ligand assay measures a binding constant, and a by-product that also binds the receptor biases the number even at low abundance, so the reference material must be as close to pure as practical. NMR and crystallography tolerate no unknown species: a contaminant produces extra signals or disordered crystals. Qualitative methods ask simpler questions. In Western blotting the question is whether a band appears, and in phosphorylation studies whether a signal is present, so moderate by-product levels do not change the answer. Polyclonal antibody production accepts the least pure material because the immune system responds to the mixture, and the goal is a titer against the target in the presence of a minority of other sequences.
Cost tracks difficulty. The relationship between purity and price is not linear. Moving from 90-95% to the 97-99% range requires additional purification passes, yield loss, and re-lyophilization, and production effort and cost can rise exponentially in that range. For most applications an intermediate grade is the economically rational choice; the highest grade is justified when the peptide is itself the measured object.
The step where QC results most often go wrong is solution preparation. The mass of target peptide in a weighed portion of powder is the product of three factors: the weighed mass, the purity, and the NPC. To deliver 1 mg of target peptide from a powder at 90% purity and 80% NPC, weigh 1.39 mg: 1 divided by 0.9 times 0.8 . A researcher who corrects for purity but not NPC will come up short by the water and salt fraction every time. Because NPC drifts with humidity, a powder stored open or in damp conditions can deliver less peptide per milligram than the certificate states; controlled, dry storage is the only way to keep the release-time figure valid at the bench.
Molar concentrations require the same correction. The molecular weight that matters is the mass of the peptide plus its counterions as the salt exists in the powder, not the mass of the peptide portion alone, because the balance weighs the salt. The certificate should state the basis of its content figure. If it lists HPLC purity but no NPC, it does not contain enough information to convert mass into peptide amount.
The certificate should also be read in context. For generic drug substances, the name may carry the notation Ph. Eur. , as in desmopressin acetate Ph. Eur., indicating that the substance follows European Pharmacopoeia specifications. For GMP products, additional microbiological analyses are performed as part of release testing; the chemical QC described here is the release standard for research-grade peptides. The results of a batch's release tests are supplied as an Analytical Data Sheet ADS or a Certificate of Analysis CofA , and the values on that document, not the label grade and not a previous batch's numbers, are the ones to use.
The evidence chain for a typical research peptide is mass spectrometric molecular weight, HPLC co-elution with a reference, and an HPLC purity. That chain establishes that the material is very likely the requested sequence at a stated purity; it does not fully prove the sequence. Amino acid analysis confirms composition, not order. A peptide with the right mass, the right retention time, and the right amino acid ratios is the best evidence standard QC can supply without a dedicated sequencing step, and it leaves a residual uncertainty that matters for experiments that depend on the exact arrangement of residues.
The consistent gap in the system is the reporting of NPC. Purity is on the label; content is what the balance actually weighs, and the two are conflated more often than any other pair of QC terms. The distinction is not academic: a basic, hydrophilic peptide of impeccable HPLC purity can deliver substantially less peptide per milligram than the purity number suggests. Researchers who plan solutions around purity alone will systematically under-dose their assays.
Batch variability is the unresolved operational problem. Lower-purity material, where variability is greatest, is exactly what qualitative studies tend to buy, and the certificate cannot predict the next batch. There is no standard requirement that suppliers identify the by-products that make up the non-main-peak fraction, so two batches with identical purity numbers can behave differently in a sensitive assay. The honest reading is that identity, purity, and NPC together describe a batch, but only the measurements on that batch describe it accurately.
Peptides referenced: Desmopressin.
Related reading: Peptide Storage and Reconstitution: A Practical Stability Guide, Peptide Purification After Synthesis: From RP-HPLC to MCSGP, Peptide Modification Overview: Types, Chemistry, and Applications, Peptide Synthesis Methods: SPPS, LPPS, CEPS, TAPS and NCL.